NasdaqCM - Delayed Quote USD

Sol-Gel Technologies Ltd. (SLGL)

7.52
+0.62
+(8.99%)
At close: June 13 at 4:00:01 PM EDT
7.01
-0.51
(-6.78%)
After hours: June 13 at 7:58:32 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
12,103
11,538
1,554
3,883
31,272
Operating Expense
--
23,552
30,859
20,127
28,308
Operating Income
-9,657
-12,014
-29,305
-16,244
2,964
Net Non Operating Interest Income Expense
--
1,434
2,067
1,321
257
Pretax Income
-13,044
-10,580
-27,238
-14,923
3,221
Tax Provision
--
--
--
--
0
Net Income Common Stockholders
-13,044
-10,580
-27,238
-14,923
3,221
Diluted NI Available to Com Stockholders
-13,044
-10,580
-27,238
-14,923
3,221
Basic EPS
-4.70
-3.80
-10.10
-6.50
1.40
Diluted EPS
-4.70
-3.80
-10.10
-6.50
1.40
Basic Average Shares
2,785.76
2,785.76
2,708.71
2,312.87
2,306.35
Diluted Average Shares
2,785.76
2,785.76
2,708.71
2,312.87
2,356.62
Total Operating Income as Reported
-9,657
-12,014
-29,305
-16,244
2,964
Total Expenses
--
23,552
30,859
20,127
28,308
Net Income from Continuing & Discontinued Operation
-13,044
-10,580
-27,238
-14,923
3,221
Normalized Income
-13,044
-10,580
-27,238
-14,923
3,221
Interest Income
--
1,434
2,067
1,321
257
Net Interest Income
--
1,434
2,067
1,321
257
EBIT
-9,657
-12,014
-29,305
-16,244
2,964
EBITDA
-9,657
-11,781
-28,963
-15,682
3,844
Reconciled Depreciation
--
233
342
562
880
Net Income from Continuing Operation Net Minority Interest
-13,044
-10,580
-27,238
-14,923
3,221
Normalized EBITDA
-9,657
-11,781
-28,963
-15,682
3,844
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/1/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALZN Alzamend Neuro, Inc.
3.2400
+1.57%
 
EQ Equillium, Inc.
0.3470
-10.22%
 
ONCO Onconetix, Inc.
4.7300
-24.90%
 
LIMN Liminatus Pharma, Inc.
14.42
-29.00%
 
KAPA Kairos Pharma, Ltd.
0.5200
-8.77%
 
ELAB PMGC Holdings Inc.
2.0800
-4.15%
 
JUNS Jupiter Neurosciences, Inc.
1.1300
+0.89%
 
ABP Abpro Corporation
0.2150
-11.85%
 
QNCX Quince Therapeutics, Inc.
1.4300
+19.17%
 
SNPX Synaptogenix, Inc.
3.7100
-23.66%